CT2377/2025 - Framework Contract for the supply of Ustekinumab 45mg Solution for Injection, Ustekinumab 90mg Solution for Injection , and Ustekinumab 130mg Concentrate for Solution for Infusion

TED · 380868-2026can-standardawardedNo deadline given

Buyer

NameDepartment of Contracts

CountryMT

Published2026-06-03

Deadline—

Value

Estimated€816,863 · 816,863 EUR

Awarded€239,690 · 239,689.54 EUR

WinnerMint Health Limited

See this firm's wins →

CPV codes

33693100 Medical equipment & pharmaceuticals

Description

CT2377/2025 - Framework Contract for the supply of Ustekinumab 45mg Solution for Injection, Ustekinumab 90mg Solution for Injection , and Ustekinumab 130mg Concentrate for Solution for Infusion

Similar tenders

Closest by meaning — across languages, via embeddings.

Published	Title	Buyer	Match
2026-05-06	CT2296/2025 - Framework Contract for the supply of Brentuximab 50mg powder for concentrate for solution for injection	Department of Contracts MT	94%
2026-06-09	CT2070/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF CANAKINUMAB 150MG/ML SOLUTION FOR INJECTION	Department of Contracts MT	92%
2026-05-26	CT2355/2025 - Framework Contract for the supply of Amoxicillin and Clavulanic Acid 1000mg/200mg Powder for Solution for Injection	Department of Contracts MT	92%
2026-04-30	CT2096/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF INSULIN DEGLUDEC 100 IU/ML SOLUTION FOR INJECTION	Department of Contracts MT	92%
2026-06-09	CT2181/2026 - Framework Contract for the supply of Fulvestrant 250mg solution for injection	Department of Contracts MT	92%
2026-05-05	CT2115/2026 - Framework Contract for supply of Adrenaline 1 in 10,000 Solution for Injection	Department of Contracts MT	92%

Source

View the official notice on TED ↗